VG LIFE SCIENCES INC (OTCMKTS:VGLS) Sellers Decreased Their Shorts By 28.83% As Of Jun 27, 2018

June 27, 2018 - By Carey Conley

VG Life Sciences Inc. (OTCMKTS:VGLS) Corporate Logo

It was registered a decrease on VG LIFE SCIENCES INC (OTCMKTS:VGLS)’s short interest with 28.83%. In June was issued VGLS’s total 31,600 short interest by FINRA. The down change of 28.83% from 44,400 shares was reported. 6 days will cost VGLS with 5,400 average volume to recover its former position.

Lastly it traded at $0.0074.It’s since June 27, 2017 and is 0.00% up. VGLS underperformed by 12.57% the S&P500.

VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation.The company has $830,901 market cap. It offers VG1177, a solution that deploys a synthesized peptide, which uses its superior binding abilities to eliminate the unwanted Class II-associated invariant chain peptide that is displayed on specific B cells that leads to chronic inflammation.Currently it has negative earnings. The firm also provides metabolic disruption technology (MDT) compounds impede tumor cells that sensitize cancer cells to treatment by disrupting the metabolic strategies those cells use to survive; and Hydroxychloroquine, a MDT compound that can be used in combination with other cancer drugs for treating drug-resistant cancers.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.